期刊文献+

Presentation of hepatocellular antigens 被引量:5

Presentation of hepatocellular antigens
原文传递
导出
摘要 The liver is an organ in which antigen-specific T-cell responses manifest a bias toward immune tolerance. This is clearly seen in the rejection of allogeneic liver transplants, and multiple other phenomena suggest that this effect is more general. These include tolerance toward antigens introduced via the portal vein, immune failure to several hepatotropic viruses, the lack of natural liverstage immunity to malaria parasites, and the frequent metastasis of cancers to the liver. Here we review the mechanisms by which T cells engage with hepatocellular antigens, the context in which such encounters occur, and the mechanisms that act to suppress a full T-cell response. While many mechanisms play a role, we will argue that two important processes are the constraints on the cross-presentation of hepatocellular antigens, and the induction of negative feedback inhibition driven by interferons. The constant exposure of the liver to microbial products from the intestine may drive innate immunity, rendering the local environment unfavorable for specific T-cell responses through this mechanism. Nevertheless, tolerance toward hepatocellular antigens is not monolithic and under specific circumstances allows both effective immunity and immunopathology. The liver is an organ in which antigen-specific T-cell responses manifest a bias toward immune tolerance. This is clearly seen in the rejection of allogeneic liver transplants, and multiple other phenomena suggest that this effect is more general. These include tolerance toward antigens introduced via the portal vein, immune failure to several hepatotropic viruses, the lack of natural liverstage immunity to malaria parasites, and the frequent metastasis of cancers to the liver. Here we review the mechanisms by which T cells engage with hepatocellular antigens, the context in which such encounters occur, and the mechanisms that act to suppress a full T-cell response. While many mechanisms play a role, we will argue that two important processes are the constraints on the cross-presentation of hepatocellular antigens, and the induction of negative feedback inhibition driven by interferons. The constant exposure of the liver to microbial products from the intestine may drive innate immunity, rendering the local environment unfavorable for specific T-cell responses through this mechanism. Nevertheless, tolerance toward hepatocellular antigens is not monolithic and under specific circumstances allows both effective immunity and immunopathology.
出处 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2016年第3期293-300,共8页 中国免疫学杂志(英文版)
关键词 liver HEPATOCYTES IMMUNITY TOLERANCE liver, hepatocytes, immunity, tolerance
  • 相关文献

参考文献90

  • 1Chassaing B, Etienne-Mesmin L, Gewirtz AT. Microbiota-liver axis in hepatic disease. Hepatology 2014; 59: 328-339. doi:10.1002/ hep.26494.
  • 2Callery MP, Kamei T, Flye MW. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J Sure Res 1989; 46: 391-394.
  • 3Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM etal. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-476.
  • 4Kamada N, Davies HS, Roser B. Reversal of transplantation immunity by liver grafting. Nature 1981; 292: 840-842.
  • 5Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995; 59: 919-921.
  • 6Vadia S, Arnett E, Haghighat AC, Wilson-Kubalek EM, Tweten RK, Seveau S. The pore-forming toxin listeriolysin 0 mediates a novel entry pathway of L. monocytogenes into human hepatocytes. PLoS PathoE2011; 7: e1002356, doi: 10.1371/journal.ppat.1002356.
  • 7Mounier J, Ryter A, Coquis-Rondon M, Sansonetti PJ. Intracellular and cell-to-cell spread of Listeria monocytogenes involves interaction with F-actin in the enterocytelike cell line Caco-2. Infect Immun 1990; 58: 1048-1058.
  • 8Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, Paterson Y. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol 2001; 167: 6471-6479.
  • 9Neeson P, Pan ZK, Paterson Y. Listeriolysin 0 is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma. Cancer Imrnunol Immunother 2008; 57: 493-505. doi: 10.1007/sOO262-OO7-O388-y.
  • 10Kim SH, Castro F, Paterson Y, Gravekamp C. High efficacy of a Listeria- based vaccine against metastatic breast cancer reveals a dual mode of action. Cancer Res 2009; 69: 5860-5866. doi: 10.1158/0008- 5472.CAN-08-4855.

同被引文献17

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部